Charles River Laboratories International (CRL) Shares Outstanding (2009 - 2025)

Charles River Laboratories International's Shares Outstanding (Entity) history runs 17 years deep, the most recent figure standing at $49.2 million for Q4 2025.

• In Q4 2025, Shares Outstanding (Entity) fell 3.76% year-over-year to $49.2 million; the TTM figure through Dec 2025 stood at $49.2 million (down 3.76% YoY), while the FY2025 annual figure was $49.2 million, down 3.76% from the prior year.
• Shares Outstanding (Entity) for Q4 2025 stood at $49.2 million, down from $51.4 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $51.7 million in Q3 2024, with the low at $49.2 million in Q4 2025.
• The 5-year median for Shares Outstanding (Entity) is $51.2 million (2024), against an average of $51.0 million.
• The sharpest annual moves came in 2021 and 2025: Shares Outstanding (Entity) gained 1.47% in 2021, then dropped 3.76% in 2025.
• Charles River Laboratories International's Shares Outstanding (Entity) stood at $50.5 million in 2021, then advanced by 0.92% to $50.9 million in 2022, then grew by 0.77% to $51.3 million in 2023, then fell by 0.38% to $51.1 million in 2024, then retreated by 3.76% to $49.2 million in 2025.
• Business Quant data shows CRL's Shares Outstanding (Entity) at $49.2 million in Q4 2025, $51.4 million in Q3 2025, and $51.3 million in Q2 2025.